系统生物学与心律失常
李翠兰,高元丰
摘要(Abstract)：
<正>1系统生物学的定义及作用尽管有关系统生物学的精确定义还存在一些争议,不过从实用的角度讲可将其定义为一种分析框架,其特征为基于系统参数对多个生物学过程进行的一种整合性描述。运用到医学上来说,首要的条件是要有一个足够大的高质量数据集,它应该囊括疾病表型和自然病史,具体到本篇涉及的当然是关
关键词(KeyWords)：
基金项目(Foundation): 国家自然科学基金项目(81170089);; 教育部博士点基金项目(20110001110046)
作者(Author): 李翠兰,高元丰
参考文献(References)：
- [1]Grace AA,Roden DM.Systems biology and cardiacarrhythmias[J].Lancet,2012,380(9852):1498-1508.
- [2]Zhou Z,Hu D.An epidemiological study on the prevalenceof atrial fibrillation in the Chinese population of mainlandChina[J].J Epidemiol,2008,18(5):209-216.
- [3]Nannenberg EA,Sijbrands EJ,Dijksman LM,et al.Mortalityof inherited arrhythmia syndromes:insight into their naturalhistory[J].Circ Cardiovasc Genet,2012,5(2):183-189.
- [4]Zhang S.Sudden cardiac death in China.Pacing ClinElectrophysiol[J].2009,32(9):1159-1162.
- [5]Moretti A,Bellin M,Welling A,et al.Patient-specific inducedpluripotent stem-cell models for long-QT syndrome[J].N EnglJ Med,2010,363(15):1397-1409.
- [6]Watanabe H,Chopra N,Laver D,et al.Flecainide preventscatecholaminergic polymorphic ventricular tachycardia in miceand humans[J].Nat Med,2009,15(4):380-383.
- [7]van der Werf C,Kannankeril PJ,Sacher F,et al.Flecainidetherapy reduces exercise-induced ventricular arrhythmiasin patients with catecholaminergic polymorphic ventriculartachycardia[J].J Am Coll Cardiol,2011,57(22):2244-2254.
- [8]Zhou Q,Xiao J,Jiang D,et al.Carvedilol and its new analogssuppress arrhythmogenic store overload-induced Ca2+release[J].Nat Med,2011,17(8):1003-1009.
- [9]Itzhaki I,Maizels L,Huber I,et al.Modelling the long QTsyndrome with induced pluripotent stem cells[J].Nature,2011,471(7337):225-229.